Insmed (INSM) Other financing activities (2013 - 2026)

Insmed's Other financing activities history runs 14 years deep, the most recent figure standing at $30.3 million for Q1 2026.

• On a quarterly basis, Other financing activities rose 2.05% year-over-year to $30.3 million in Q1 2026; TTM through Mar 2026 was $136.3 million, a 1.85% decrease from a year earlier, with the FY2025 full-year figure at $135.7 million, up 19.85% from the prior year.
• Other financing activities declined to $30.3 million in Q1 2026 per INSM's latest filing, from $34.6 million in the prior quarter.
• Across five years, Other financing activities topped out at $68.6 million in Q2 2024 and bottomed at $1.1 million in Q1 2023.
• The 5-year median for Other financing activities is $7.6 million (2023), against an average of $18.7 million.
• Across the five-year window, Other financing activities plunged 83.29% in 2023 and surged 1048.23% in 2024, its largest moves.
• Year by year, Other financing activities stood at $2.2 million in 2022, then jumped by 251.73% to $7.6 million in 2023, then jumped by 79.94% to $13.7 million in 2024, then jumped by 152.07% to $34.6 million in 2025, then dropped by 12.48% to $30.3 million in 2026.
• Per Business Quant, the three latest INSM Other financing activities figures stand at $30.3 million (Q1 2026), $34.6 million (Q4 2025), and $34.4 million (Q3 2025).